Combination Medication for Treating the Effects of Stomach Acid Reduction Medication on Bone Integrity
OwnerRenjit Sundharadasinventor
Life of this patent
Estimating the term…
Abstract
A composition for addressing a calcium deficiency caused by chronic administration of proton pump inhibitors and other acid lowering agents comprised of at least one proton pump inhibitor and vitamin D. The composition can further include one or more of the following: at least one buffering agent in an amount sufficient to increase gastric fluid pH to a pH that prevents acid degradation of at least a portion of the proton pump inhibitor in the gastric fluid, a therapeutically effective amount of at least one non-steroidal anti-inflammatory drug, a therapeutically effective amount of at least one bisphosphonate or selective estrogen receptor modulator, and at least one calcium supplement.
Claims22
A composition for treating the effects of stomach acid reduction medication on bone integrity comprised of:
- a therapeutically effective amount of at least one proton pump inhibitor;
- and
- a therapeutically effective amount of vitamin D.
A pharmaceutical composition comprising:
- a therapeutically effective amount of at least one proton pump inhibitor;
- a therapeutically effective amount of vitamin D;
- and
- at least one buffering agent in an amount sufficient to increase gastric fluid pH to a pH that prevents acid degradation of at least a portion of said at least one proton pump inhibitor in said gastric fluid.
A combination medication for treating osteoporosis or osteopenia comprised of:
- a therapeutically effective amount of at least one proton pump inhibitor;
- a therapeutically effective amount of vitamin D;
- and
- a therapeutically effective amount of at least one bisphosphonate or at least one selective estrogen receptor.
Dependencies are inferred from the claim text.